NCT02402868View on ClinicalTrials.gov

Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

February 28, 2018

Conditions
Bone Fractures
Interventions
DRUG

Ketamine and saline

Ketamine intravenous and intranasal

Trial Locations (1)

N6A5W9

Children's Hospital, London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02402868 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children | Biotech Hunter | Biotech Hunter